This document provides guidance on incident management and root cause analysis for NHS screening programs. It describes what constitutes a screening safety incident and outlines requirements for managing safety concerns, incidents, and serious incidents. The Safety Incident Assessment Form is used for fact-finding and recommending actions. It also discusses accountability, roles, and responsibilities and recommends using a RASCI framework. Root cause analysis is described as an evidence-based process to identify the underlying causes of problems in order to develop targeted actions to prevent recurrence.
15.45 p.m. 16.30 p.m. - learning from audits pbPHEScreening
This document summarizes the results of an audit of multi-disciplinary operational group meetings across several NHS cancer screening programs. The audit found variability in adherence to standards, with only two of five programs meeting monthly as required. Meeting attendance was incomplete, and one program did not take minutes. The audit recommendations include holding monthly meetings according to guidelines, establishing terms of reference, and regularly minute-taking and auditing meetings to improve adherence to standards.
13.50 p.m. competency and development techs vrPHEScreening
The document discusses the roles and responsibilities of Clinical Skills Trainers (CSTs) and Ultrasound Leads in abdominal aortic aneurysm screening programs. CSTs are responsible for training screening technicians, monitoring image quality, reviewing atypical findings, and equipment maintenance. Ultrasound Leads monitor staff accreditation and image quality assurance, review incidental findings, and perform equipment maintenance. Both CSTs and Ultrasound Leads assess trends in screening outcomes, provide quarterly feedback to technicians, and support technicians' professional development. The document explores how data systems and feedback can help CSTs and Ultrasound Leads fulfill these responsibilities.
NHS screening leaflet short urls and qr codes PDFPHEScreening
This document provides short URLs and QR codes for digital information leaflets about various NHS screening programs in the UK, including antenatal and newborn, AAA, bowel cancer, breast cancer, cervical cancer, and diabetic eye screening. Short URLs and QR codes are included to easily direct people to online collections of digital information leaflets for each screening program through mobile devices.
NHS screening leaflet short urls and qr codesPHEScreening
This document provides short URLs and QR codes for digital information leaflets about various NHS screening programs in the UK, including antenatal and newborn, AAA, bowel cancer, breast cancer, cervical cancer, and diabetic eye screening. Short URLs and QR codes are included to easily direct people to online collections of digital information leaflets for each screening program through mobile devices.
PHE screening inequalities conference final slidesPHEScreening
This document outlines plans for a conference on addressing inequalities in screening. The aims of the conference are to share information on actions being taken to tackle inequalities, seek expert input on further steps, and discuss successes and new learning. The document provides background on PHE's screening inequalities strategy, examples of data showing inequalities, and initiatives underway like the FIT screening implementation and health equity audit toolkit. Speakers will discuss evidence-based practices to address inequalities including effective invitee interventions and potential program-level changes. The final section covers accessing screening data to support inequalities work while complying with information governance.
1) The document discusses health inequalities and screening inequalities, noting that uptake rates tend to be lower for those in more deprived socioeconomic groups and for certain minority populations.
2) It provides an overview of the Public Health England's Screening Division Inequalities Strategy, which aims to increase uptake in the most deprived areas by 10% by addressing barriers to screening.
3) The strategy involves tools to help services analyze uptake data and identify groups with lower participation, as well as guidance on improving access for populations such as those with severe mental illness.
This document provides guidance on incident management and root cause analysis for NHS screening programs. It describes what constitutes a screening safety incident and outlines requirements for managing safety concerns, incidents, and serious incidents. The Safety Incident Assessment Form is used for fact-finding and recommending actions. It also discusses accountability, roles, and responsibilities and recommends using a RASCI framework. Root cause analysis is described as an evidence-based process to identify the underlying causes of problems in order to develop targeted actions to prevent recurrence.
15.45 p.m. 16.30 p.m. - learning from audits pbPHEScreening
This document summarizes the results of an audit of multi-disciplinary operational group meetings across several NHS cancer screening programs. The audit found variability in adherence to standards, with only two of five programs meeting monthly as required. Meeting attendance was incomplete, and one program did not take minutes. The audit recommendations include holding monthly meetings according to guidelines, establishing terms of reference, and regularly minute-taking and auditing meetings to improve adherence to standards.
13.50 p.m. competency and development techs vrPHEScreening
The document discusses the roles and responsibilities of Clinical Skills Trainers (CSTs) and Ultrasound Leads in abdominal aortic aneurysm screening programs. CSTs are responsible for training screening technicians, monitoring image quality, reviewing atypical findings, and equipment maintenance. Ultrasound Leads monitor staff accreditation and image quality assurance, review incidental findings, and perform equipment maintenance. Both CSTs and Ultrasound Leads assess trends in screening outcomes, provide quarterly feedback to technicians, and support technicians' professional development. The document explores how data systems and feedback can help CSTs and Ultrasound Leads fulfill these responsibilities.
NHS screening leaflet short urls and qr codes PDFPHEScreening
This document provides short URLs and QR codes for digital information leaflets about various NHS screening programs in the UK, including antenatal and newborn, AAA, bowel cancer, breast cancer, cervical cancer, and diabetic eye screening. Short URLs and QR codes are included to easily direct people to online collections of digital information leaflets for each screening program through mobile devices.
NHS screening leaflet short urls and qr codesPHEScreening
This document provides short URLs and QR codes for digital information leaflets about various NHS screening programs in the UK, including antenatal and newborn, AAA, bowel cancer, breast cancer, cervical cancer, and diabetic eye screening. Short URLs and QR codes are included to easily direct people to online collections of digital information leaflets for each screening program through mobile devices.
PHE screening inequalities conference final slidesPHEScreening
This document outlines plans for a conference on addressing inequalities in screening. The aims of the conference are to share information on actions being taken to tackle inequalities, seek expert input on further steps, and discuss successes and new learning. The document provides background on PHE's screening inequalities strategy, examples of data showing inequalities, and initiatives underway like the FIT screening implementation and health equity audit toolkit. Speakers will discuss evidence-based practices to address inequalities including effective invitee interventions and potential program-level changes. The final section covers accessing screening data to support inequalities work while complying with information governance.
1) The document discusses health inequalities and screening inequalities, noting that uptake rates tend to be lower for those in more deprived socioeconomic groups and for certain minority populations.
2) It provides an overview of the Public Health England's Screening Division Inequalities Strategy, which aims to increase uptake in the most deprived areas by 10% by addressing barriers to screening.
3) The strategy involves tools to help services analyze uptake data and identify groups with lower participation, as well as guidance on improving access for populations such as those with severe mental illness.
The document discusses health inequalities in cancer screening programs. It aims to familiarize screening technicians with health inequalities, update them on initiatives to address inequalities from the UK Public Health England screening division, and explore further actions that could be taken. It notes that screening inequalities exist for groups experiencing economic deprivation, minority ethnic groups, people with disabilities, and other protected groups. Addressing inequalities requires understanding differences in participation within and between screening programs and targeting groups at higher risk who are less likely to participate. Actions discussed include analyzing screening data to identify inequalities, making programs more accessible, and establishing collaboration groups to share information.
1) The document discusses health inequalities in cancer screening programs. It notes that uptake rates tend to be lower for populations experiencing economic deprivation, belonging to minority ethnic groups, or having disabilities.
2) Data is presented showing gaps in life expectancy between deprived and affluent areas of up to 9 years for males. Screening coverage and outcomes also tend to be lower for disadvantaged groups.
3) Actions are proposed to improve accessibility of screening for people with disabilities or severe mental illness through targeted outreach and accommodations. Establishing collaborations through online platforms and sharing work at program board meetings is encouraged.
This document discusses health inequalities and screening inequalities. It aims to refresh knowledge on health inequalities, update on the Public Health England screening division's inequalities strategy, and explore actions screening nurses can take to tackle inequalities. It provides data showing screening uptake disparities based on factors like learning disabilities, ethnicity, and socioeconomic status. It also outlines guidance and tools to help screening services increase uptake in deprived areas and make screening more accessible for groups facing inequalities.
AAA Screening : Extending the screener rolePHEScreening
This document describes extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. It provides details on the current and proposed screening models, including the additional training and guidance technicians receive to take blood pressure and seek nurse advice. An example is given of how a high blood pressure reading was identified during screening and subsequently treated, benefiting both the patient and their GP. Feedback from patients and GPs is positive about the expanded technician role in detecting other health issues alongside AAA screening.
AAA Screening : Extending the screener role for nursesPHEScreening
The document discusses extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. The program saw a decline in eligible men for screening over time as the population grew. The extended screener role would have technicians take basic observations like blood pressure and seek nurse practitioner advice if needed. Patients would receive education materials and follow up calls. Nurses would conduct further assessments over the phone. The changes aim to catch other health issues and assure quality through training, audits, and patient and doctor feedback. The feedback received has been positive.
AAA screening national programme update September 2019: Lisa SummersPHEScreening
This document provides a national update on the AAA screening programme in the UK. It discusses updates to clinical leads, screening figures, key performance indicators, standards and guidance, IT systems, equipment evaluation, rationale for modifying surveillance intervals, and initiatives across the four nations and to address inequalities in screening.
Improving outcomes of patients on AAA surveillance Adam HaquePHEScreening
This document discusses improving outcomes for patients undergoing abdominal aortic aneurysm (AAA) surveillance through exercise interventions. It presents evidence that cardiovascular fitness, as measured by cardiopulmonary exercise testing (CPET), is a key determinant of outcomes for AAA patients. A trial is proposed to evaluate the effects of a 24-week patient-directed exercise program on CPET measures of fitness for AAA surveillance patients compared to standard advice. The goal is to determine if objective measures of cardiovascular fitness can be improved through a scalable and deliverable exercise program to provide benefits like reduced peri-operative risk and improved survival for AAA patients.
AAA nurses training: programme boards presentation September 2019PHEScreening
This document discusses programme boards for screening quality assurance. It notes that nurses rarely attend all programme boards due to small team sizes and priority being given to patient assessments. Programme boards ensure screening programmes meet national standards and involve multiple stakeholder organizations. They discuss performance against quality standards, learning from incidents, and service improvement initiatives. The most discussed topics include performance metrics, incidents and lessons learned, quality assurance visit outcomes, and risks/mitigation plans. Nursing contributions could involve audits on access, uptake, and waiting times. Key messages from boards should be communicated to nursing teams.
AAA screeners LGBT awareness training September 2019PHEScreening
The document discusses LGBTQ+ awareness in abdominal aortic aneurysm screening programs, including definitions of key terms like sexual orientation, gender identity, and pronouns. It also notes potential health inequalities faced by LGBTQ+ people and how current AAA screening procedures and invitations may need improvements to be more inclusive of transgender and non-binary individuals.
Digital screening information event 2 October 2019PHEScreening
Slides from the event for antenatal screening co-ordinators in Birmingham on 2 October 2019 to discuss the plans for moving to digital screening information.
NHS Breast Screening Programme & Association of Breast Surgery AuditPHEScreening
The document describes the NHS Breast Screening Programme (NHSBSP) and Association of Breast Surgery (ABS) audit. The audit compares surgical data to quality assurance standards to assess performance. It analyzes data on all breast cancers detected through screening in the UK each year. The annual audit has three parts - the main audit examines the most recent year's data, the adjuvant audit examines treatment data from the prior year, and the survival audit examines 5-year survival rates. The document provides guidance on extracting data from the NBSS database system, checking the data for errors or missing information, and resolving issues by updating records in NBSS before uploading the data to the Breast Screening System Information System (BSIS
This document provides an update on the Infectious Diseases in Pregnancy Screening (IDPS) Programme in the UK. It discusses the aims of the programme, which include enabling early detection and treatment of infections in pregnancy to reduce mother-to-child transmission. It summarizes screening activity data which shows high uptake rates of over 99% for HIV, hepatitis B, and syphilis screening. It also discusses efforts to improve laboratory quality, establish screening standards and outcomes data, and provide education resources to professionals and the public. Specific updates are provided on actions relating to HIV, syphilis, hepatitis B, and developing seamless maternal and neonatal pathways between screening and immunization programs.
10. Siobhan O'callaghan findings from QA activitiesPHEScreening
The QA advisor summarizes findings from 30 QA visits reports between September 2017 and July 2018. A total of 786 QA recommendations were made across various themes. The top theme was infectious diseases in pregnancy, receiving 218 recommendations. Of these, 61 recommendations were specific to the laboratory, focusing on issues like properly identifying and tracking antenatal samples, notifying screening results, and ensuring UKAS accreditation. Generic recommendations that appeared across themes included formalizing governance, managing incidents, and meeting standards for staff training and turnaround times.
9. Judith Timms HIV screening incidentsPHEScreening
This document discusses false positive HIV results that can occur during HIV screening. The main causes of false positives are wrong blood in the tube or laboratory error. Laboratory error is found to be the most common cause, responsible for false positives in 8 of 9 cases reviewed from 2014 to 2017. Specific cases of laboratory errors are presented, including possible contamination during automated testing processes and issues with old laboratory equipment. The implications of false positive results, such as distress to patients, are also covered.
8. Nadia Permalloo learning from incidentsPHEScreening
This document summarizes themes from quarterly incident reports of a screening program covering October 2015 to December 2017. Key issues identified include screening without informed consent, insufficient samples not being repeated in a timely manner, tracking and communication failures leading to unreported positive screening results, delays when using reference laboratories, and unconfirmed screening results being communicated to patients. The document concludes with a checklist of questions around improving processes to address these issues.
7. Tom Lewis Getting it right for pathology presentationPHEScreening
This document summarizes a presentation on the Getting It Right First Time (GIRFT) program and its workstream focused on pathology. GIRFT aims to reduce unwarranted variation in clinical care through data collection, identifying best practices, and promoting changes. The pathology workstream is led by four clinical leads and aims to measure current variability in pathology services, create a vision for the future, and test changes. Key activities will include collecting data through questionnaires and site visits to understand variations and identify opportunities for improvement.
6. Madeline McMahon IDPS workshop 13 march v2.0PHEScreening
The document discusses standards for infectious disease screening in pregnancy. It outlines 7 standards for screening coverage and test turnaround time. Standard 4 focuses on the test turnaround time for HIV, hepatitis B, and syphilis screening, requiring results be reported within 8 working days of sample receipt. Performance is tracked by region. Common issues with submitting data are outlined, and a proposed change to the submission template is presented to help clarify reporting of pending or inconclusive results. Laboratories are responsible for submitting Standard 4 data to maternity services by the end of June for the previous year's reporting period.
This document outlines an algorithm and provides comments for interpreting and reporting results from HIV screening tests. It describes the typical screening and confirmation testing process and provides guidance on interpreting various result patterns. It also includes questions and discussion points about challenging result scenarios and sample storage requirements. The goal is to help standardize the interpretation and reporting of HIV screening test results.
4. Samir Dervisevic hepatitis b antenatal screening algorithms and reportingPHEScreening
This document discusses hepatitis B screening algorithms and reporting for pregnant women in the UK. It provides background on the national screening program and standards for viral hepatitis B screening during pregnancy. The goals of antenatal hepatitis B screening are early detection of infection to enable treatment for the mother and reduce mother-to-child transmission risk by offering newborn vaccination and prophylaxis. The document reviews epidemiology data on acute hepatitis B cases in Europe and England and outlines the clinical outcome and diagnosis of hepatitis B infection through various serological markers. It presents the hepatitis B testing algorithm and provides clinical comments for reporting screening test results.
3. Ruth White syphilis presentation march 2019 (rw)PHEScreening
This document outlines the syphilis testing algorithm and reporting procedures used in antenatal screening. It describes a multi-step process where an initial EIA/CLIA screening test is followed by confirmatory TPPA/TPHA and RPR tests to determine if a sample is positive, negative, or inconclusive. Inconclusive results require a repeat sample in 2 weeks and may be sent to a reference laboratory. All results must be reported within 8 days to allow timely clinical evaluation and treatment if needed. The goal is to accurately detect syphilis infection status while avoiding false results and ensuring pregnant women receive appropriate care.
The document discusses health inequalities in cancer screening programs. It aims to familiarize screening technicians with health inequalities, update them on initiatives to address inequalities from the UK Public Health England screening division, and explore further actions that could be taken. It notes that screening inequalities exist for groups experiencing economic deprivation, minority ethnic groups, people with disabilities, and other protected groups. Addressing inequalities requires understanding differences in participation within and between screening programs and targeting groups at higher risk who are less likely to participate. Actions discussed include analyzing screening data to identify inequalities, making programs more accessible, and establishing collaboration groups to share information.
1) The document discusses health inequalities in cancer screening programs. It notes that uptake rates tend to be lower for populations experiencing economic deprivation, belonging to minority ethnic groups, or having disabilities.
2) Data is presented showing gaps in life expectancy between deprived and affluent areas of up to 9 years for males. Screening coverage and outcomes also tend to be lower for disadvantaged groups.
3) Actions are proposed to improve accessibility of screening for people with disabilities or severe mental illness through targeted outreach and accommodations. Establishing collaborations through online platforms and sharing work at program board meetings is encouraged.
This document discusses health inequalities and screening inequalities. It aims to refresh knowledge on health inequalities, update on the Public Health England screening division's inequalities strategy, and explore actions screening nurses can take to tackle inequalities. It provides data showing screening uptake disparities based on factors like learning disabilities, ethnicity, and socioeconomic status. It also outlines guidance and tools to help screening services increase uptake in deprived areas and make screening more accessible for groups facing inequalities.
AAA Screening : Extending the screener rolePHEScreening
This document describes extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. It provides details on the current and proposed screening models, including the additional training and guidance technicians receive to take blood pressure and seek nurse advice. An example is given of how a high blood pressure reading was identified during screening and subsequently treated, benefiting both the patient and their GP. Feedback from patients and GPs is positive about the expanded technician role in detecting other health issues alongside AAA screening.
AAA Screening : Extending the screener role for nursesPHEScreening
The document discusses extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. The program saw a decline in eligible men for screening over time as the population grew. The extended screener role would have technicians take basic observations like blood pressure and seek nurse practitioner advice if needed. Patients would receive education materials and follow up calls. Nurses would conduct further assessments over the phone. The changes aim to catch other health issues and assure quality through training, audits, and patient and doctor feedback. The feedback received has been positive.
AAA screening national programme update September 2019: Lisa SummersPHEScreening
This document provides a national update on the AAA screening programme in the UK. It discusses updates to clinical leads, screening figures, key performance indicators, standards and guidance, IT systems, equipment evaluation, rationale for modifying surveillance intervals, and initiatives across the four nations and to address inequalities in screening.
Improving outcomes of patients on AAA surveillance Adam HaquePHEScreening
This document discusses improving outcomes for patients undergoing abdominal aortic aneurysm (AAA) surveillance through exercise interventions. It presents evidence that cardiovascular fitness, as measured by cardiopulmonary exercise testing (CPET), is a key determinant of outcomes for AAA patients. A trial is proposed to evaluate the effects of a 24-week patient-directed exercise program on CPET measures of fitness for AAA surveillance patients compared to standard advice. The goal is to determine if objective measures of cardiovascular fitness can be improved through a scalable and deliverable exercise program to provide benefits like reduced peri-operative risk and improved survival for AAA patients.
AAA nurses training: programme boards presentation September 2019PHEScreening
This document discusses programme boards for screening quality assurance. It notes that nurses rarely attend all programme boards due to small team sizes and priority being given to patient assessments. Programme boards ensure screening programmes meet national standards and involve multiple stakeholder organizations. They discuss performance against quality standards, learning from incidents, and service improvement initiatives. The most discussed topics include performance metrics, incidents and lessons learned, quality assurance visit outcomes, and risks/mitigation plans. Nursing contributions could involve audits on access, uptake, and waiting times. Key messages from boards should be communicated to nursing teams.
AAA screeners LGBT awareness training September 2019PHEScreening
The document discusses LGBTQ+ awareness in abdominal aortic aneurysm screening programs, including definitions of key terms like sexual orientation, gender identity, and pronouns. It also notes potential health inequalities faced by LGBTQ+ people and how current AAA screening procedures and invitations may need improvements to be more inclusive of transgender and non-binary individuals.
Digital screening information event 2 October 2019PHEScreening
Slides from the event for antenatal screening co-ordinators in Birmingham on 2 October 2019 to discuss the plans for moving to digital screening information.
NHS Breast Screening Programme & Association of Breast Surgery AuditPHEScreening
The document describes the NHS Breast Screening Programme (NHSBSP) and Association of Breast Surgery (ABS) audit. The audit compares surgical data to quality assurance standards to assess performance. It analyzes data on all breast cancers detected through screening in the UK each year. The annual audit has three parts - the main audit examines the most recent year's data, the adjuvant audit examines treatment data from the prior year, and the survival audit examines 5-year survival rates. The document provides guidance on extracting data from the NBSS database system, checking the data for errors or missing information, and resolving issues by updating records in NBSS before uploading the data to the Breast Screening System Information System (BSIS
This document provides an update on the Infectious Diseases in Pregnancy Screening (IDPS) Programme in the UK. It discusses the aims of the programme, which include enabling early detection and treatment of infections in pregnancy to reduce mother-to-child transmission. It summarizes screening activity data which shows high uptake rates of over 99% for HIV, hepatitis B, and syphilis screening. It also discusses efforts to improve laboratory quality, establish screening standards and outcomes data, and provide education resources to professionals and the public. Specific updates are provided on actions relating to HIV, syphilis, hepatitis B, and developing seamless maternal and neonatal pathways between screening and immunization programs.
10. Siobhan O'callaghan findings from QA activitiesPHEScreening
The QA advisor summarizes findings from 30 QA visits reports between September 2017 and July 2018. A total of 786 QA recommendations were made across various themes. The top theme was infectious diseases in pregnancy, receiving 218 recommendations. Of these, 61 recommendations were specific to the laboratory, focusing on issues like properly identifying and tracking antenatal samples, notifying screening results, and ensuring UKAS accreditation. Generic recommendations that appeared across themes included formalizing governance, managing incidents, and meeting standards for staff training and turnaround times.
9. Judith Timms HIV screening incidentsPHEScreening
This document discusses false positive HIV results that can occur during HIV screening. The main causes of false positives are wrong blood in the tube or laboratory error. Laboratory error is found to be the most common cause, responsible for false positives in 8 of 9 cases reviewed from 2014 to 2017. Specific cases of laboratory errors are presented, including possible contamination during automated testing processes and issues with old laboratory equipment. The implications of false positive results, such as distress to patients, are also covered.
8. Nadia Permalloo learning from incidentsPHEScreening
This document summarizes themes from quarterly incident reports of a screening program covering October 2015 to December 2017. Key issues identified include screening without informed consent, insufficient samples not being repeated in a timely manner, tracking and communication failures leading to unreported positive screening results, delays when using reference laboratories, and unconfirmed screening results being communicated to patients. The document concludes with a checklist of questions around improving processes to address these issues.
7. Tom Lewis Getting it right for pathology presentationPHEScreening
This document summarizes a presentation on the Getting It Right First Time (GIRFT) program and its workstream focused on pathology. GIRFT aims to reduce unwarranted variation in clinical care through data collection, identifying best practices, and promoting changes. The pathology workstream is led by four clinical leads and aims to measure current variability in pathology services, create a vision for the future, and test changes. Key activities will include collecting data through questionnaires and site visits to understand variations and identify opportunities for improvement.
6. Madeline McMahon IDPS workshop 13 march v2.0PHEScreening
The document discusses standards for infectious disease screening in pregnancy. It outlines 7 standards for screening coverage and test turnaround time. Standard 4 focuses on the test turnaround time for HIV, hepatitis B, and syphilis screening, requiring results be reported within 8 working days of sample receipt. Performance is tracked by region. Common issues with submitting data are outlined, and a proposed change to the submission template is presented to help clarify reporting of pending or inconclusive results. Laboratories are responsible for submitting Standard 4 data to maternity services by the end of June for the previous year's reporting period.
This document outlines an algorithm and provides comments for interpreting and reporting results from HIV screening tests. It describes the typical screening and confirmation testing process and provides guidance on interpreting various result patterns. It also includes questions and discussion points about challenging result scenarios and sample storage requirements. The goal is to help standardize the interpretation and reporting of HIV screening test results.
4. Samir Dervisevic hepatitis b antenatal screening algorithms and reportingPHEScreening
This document discusses hepatitis B screening algorithms and reporting for pregnant women in the UK. It provides background on the national screening program and standards for viral hepatitis B screening during pregnancy. The goals of antenatal hepatitis B screening are early detection of infection to enable treatment for the mother and reduce mother-to-child transmission risk by offering newborn vaccination and prophylaxis. The document reviews epidemiology data on acute hepatitis B cases in Europe and England and outlines the clinical outcome and diagnosis of hepatitis B infection through various serological markers. It presents the hepatitis B testing algorithm and provides clinical comments for reporting screening test results.
3. Ruth White syphilis presentation march 2019 (rw)PHEScreening
This document outlines the syphilis testing algorithm and reporting procedures used in antenatal screening. It describes a multi-step process where an initial EIA/CLIA screening test is followed by confirmatory TPPA/TPHA and RPR tests to determine if a sample is positive, negative, or inconclusive. Inconclusive results require a repeat sample in 2 weeks and may be sent to a reference laboratory. All results must be reported within 8 days to allow timely clinical evaluation and treatment if needed. The goal is to accurately detect syphilis infection status while avoiding false results and ensuring pregnant women receive appropriate care.
3. Ruth White syphilis presentation march 2019 (rw)
15.45 p.m. 16.30 p.m. learning from incidents - pb
1. Public Health England leads the NHS Screening Programmes
CST and Screening Technician
Workshop – 10 November 2016
-What can we learn from reported
AAA screening incidents?
Paola Beresh, QA Advisor, SQAS (London)
2. Reported LondonAAAincidents (December 2014 to
October 2016)
Learning from AAA incidents
2.
AVEs - 8
SI- 1
SSIs - 2
Non Screening - 2
AVE - 8
SI - 1
SSI - 2
Non
Screening - 2
SI - 1
Non
Screening
Incidents - 4
No Concern - No Further Action
Problem Still Suspected - Further Investigation Required
Problem Confirmed - To be managed Internally
SSIs (internal and multi-disciplinary)
SIs
No concern - 6
Managed Internally - 9
SSI - 17
SI -1
Still Suspected - 2
Classification
Source: PHE incident
Trackwise database and
submitted SIAFs
3. Reported LondonAAAincidents (December 2014 to
October 2016)
0
1
2
3
4
5
6
7
8
AAASP1 AAASP2 AAASP3 AAASP4 AAASP5
SI Reported
SSI Reported
Problem Confirmed - To be managed internally
Problem Still Suspected - Further Investigation Required
No Concern - No further action
7 SSI
1 Mgd Internally
2 Still Suspected
2 No Concern
3 SSI
2 Managed Internally
3. Learning from Incidents
3 SSI
1 Managed Internally
1 SI
2 SSI
2 Managed Internally
2 No Concern
2 SSI
3 Managed Internally
2 No Concern
Classification by screening service
4. Open
Closed
Closed – 20
Open – 15
4. Learning form Incidents
Reported LondonAAAincidents (December 2014 to
October 2016)
Incident status
5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
A 165 38 6 133 283 0 2 7 36 19 3 26 28 124 55 24 167 0 57 19 84 91 16 6 1 0 17
B 71 2 11 13 17 32 215 7 12 1 33 2 9 13 333 0 64 5 0 10 13 41 0 11 3 3 1
C 0 127 19 14 125 46 0 138 0 5 0 161 0 0 338 0 65 7 0 0 37 0 1 19 10 0 0
D 236 137 25 147 408 46 511 145 405 234 0 118 0 0 0 0 0 0 0 0 0 0 16 17 0 0 0
0
100
200
300
400
500
600
D
a
y
s
Days taken to complete each stage of an incident
A = Between Date Incident
Identified and SIAF
Received
B= Between SIAF received
and Section 2 completed
C= Between SIAF received and
Section 3 received
D= Between Incident Identified
and Closure
Timescales for incident management stages
5. Learning from Incidents
6. Themes- incident grouped by similarities
1 5 2 1 1 2 1 2 1 1 4
1
1 5 21
1021
690
62
12 2 Unknown
0 21 13
Number of incidents No of People Affected
Unknown
6. Learning from Incidents
7. Lessons Learnt
7 Learnings from Incidents
Theme Lessons Learnt
Ultrasound Machines not
serviced
Robust process to monitor maintenance of
equipment.
Closer monitoring of contracts when up for
renewal
Delayed Printing of GP
result letters
Protocol for letter administration with a failsafe
spreadsheet to robustly monitor numbers of
letters printed.
GP Unregistered Patients Issue a letter to patients when they unregister
from a GP alerting them to the fact that they need
to register with a GP to be invited for screening
Establish a review period to give GP unregistered
patients an opportunity to reregister and be
reinvited
8. Lessons Learnt
Theme Lessons Learnt
Breach in 8 week referral to surgery
due to Hospital Factors
Robust referral and tracking process
with clear timescales and duties of
the team members outlined.
Medical history checks to be
strengthened in assessment clinics.
Appropriate administrative support to
track patients post-MDM discussion
and flag issues to service directorate
Only NASSP measurements to be
included on SMART
8 Learnings from Incidents
9. 9 Learning from Incidents
1 8 3 2 1 1 1
1
1
1 21 5 1 0 Unknown
0 1
326
Number of incidents No of People Affected
Reported NationalAAAincidents
(April to October 2016) Themes
10. 10 Learning from Incidents
Reported NationalAAAincidents
(April to October 2016)
Regional breakdown
Region Number of incidents Number of people
affected
London 10 111*
South West 4 4”
East of England 3 5
South East 3 14
North East Yorkshire
and Humber
4 4*
East Midlands 3 2*
National 2 326
Total 29 466
Editor's Notes
Key point variation in reporting
Random selection of screening SIAFS
Key point variation in time taken between pathway from date of incident
Grouped by similarities
Varying severity
What is the likelihood of these re-occuring?
Are they recurring and is it happening within your screening service
* SIAFs that have an unknown number of affected people e.gl reporting high non vis rate